About Paviour Pharmaceuticals Private Limited
Data last updated:
Paviour Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 September 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1998PTC095875. Its GSTIN is 07AABCP9154E1ZF (Delhi). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹62 Lakh. It is led by directors Anil Sawhney and Neeru Sawhney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 311 – 312 Suneja Tower I Distt Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.47 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.46 Cr (net margin 1.7%) and EBITDA of ₹2.52 Cr (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 11% over five years.
The company has about 57 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Paviour. As per MCA filings, the company has open charges of ₹7.04 Cr and satisfied charges of ₹1.19 Cr on record. Court records list 3 cases involving the company, including 3 filed against it. The company has 17 deals on record (11 secondary share transfers, 6 funding rounds), with disclosed funding of ₹3 Cr; the latest was in March 2024. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Omkar Medical Distributors Private Limited with revenue of ₹88.28 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website paviour.org.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address311 – 312 Suneja Tower I Distt Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Paviour Pharmaceuticals Private Limited
The main business activity of Paviour Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Paviour Pharmaceuticals Private Limited FY 2025 filings available
Paviour Pharmaceuticals Private Limited reported revenue of ₹87.47 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Paviour Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 14% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Paviour Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.52 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.46 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Paviour Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Paviour Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omkar Medical Distributors Private Limited | ₹88.28 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| SRS Pharmaceuticals Private Limited | ₹88.26 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Amtec Health Care Private Limited | ₹87.91 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| Shiva Medi Services Private Limited | ₹87.76 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Kolkata, West Bengal, India |
| Innovcare Lifesciences Private Limited | ₹87.72 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Paviour Pharmaceuticals Private Limited this company | ₹87.47 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Alfaone Medicals Private Limited | ₹86.94 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Bangalore, Karnataka, India |
| Shree Maruti Nandan Pharmaceuticals Private Limited | ₹86.33 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Eris Healthcare Private Limited | ₹85.67 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Ahmedabad, Gujarat, India |
| Mediways Enterprises Private Limited | ₹85.66 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Uttar Pradesh, India |
| D.D. Pharmaceuticals Pvt. Ltd | ₹85.6 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Sitapura, Tonk Road, Jaipur., Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Paviour Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited is audited by Manish Mohan Agrawal & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Manish Mohan Agrawal & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Sawhney | Director | 01 Sep 1998 | 28 Years 1 Months | Current |
| Neeru Sawhney | Director | 01 Sep 1998 | 28 Years 1 Months | Current |
Ownership and Shareholding of Paviour Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Paviour Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2023 | Hdfc Bank Limited | ₹60 Lakh | Open |
| 05 Jan 2021 | Hdfc Bank Limited | ₹6.44 Cr | Open |
| 22 Sep 2004 | State Bank of India | ₹1.19 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited has 17 deals on record (11 secondary share transfers, 6 funding rounds), with disclosed funding of ₹3 Cr; the latest was in March 2024.
Deals on record (5 of 17)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Tarseem Lal Sondhi (HUF), Vibhash Creations Private Limited , 2 individuals |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: R.K. Tradeexpo Private Limited , Sreeram E Techno School Private Limited , Luv Kush Technologies Private Limited |
| Oct 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Sreeram E Techno School Private Limited , Tarseem Lal Sondhi (HUF), 2 individuals |
| Nov 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Euphoria Capital Private Limited , Kesri Lab (Electronics) Private Limited , Anubhav Buildmart Private Limited , an individual |
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: Anil Sawhney (Huf), Tarseem Lal Sondhi (HUF), 2 individuals Seller: Balaji Traders, Tara Enterprises, 2 individuals |
Full deal history
All 17 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Kerala | Court case (OP(C)) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by CSL Behring Ag & Anr | Disposed |
| District court, Thiruvananthapuram, Kerala | Civil suit | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals operates one associated brand: Paviour. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Importing, marketing, and distribution of pharmaceutical specialty products in India. | paviour.org |
Employees and EPFO Compliance at Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited has a workforce of 57 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Anil Sawhney was appointed as Director on 01 Sep 1998.
Credit Ratings, Litigation & Regulatory Alerts for Paviour Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Paviour Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Paviour Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCP9154E1ZF | Delhi | Active | 01 Jul 2017 |
| 19AABCP9154E1ZA | West Bengal | Active | 01 Jul 2017 |
| 22AABCP9154E1ZN | Chhattisgarh | Active | 01 Jul 2017 |
| 27AABCP9154E1ZD | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Paviour Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paviour Pharmaceuticals Private Limited
Paviour Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 September 1998 (28+ years old) and is registered under CIN U24231DL1998PTC095875.
Paviour Pharmaceuticals reported revenue of ₹87.47 Cr for FY 2025 (up 14% YoY).
Paviour Pharmaceuticals has 2 current directors:
- Anil Sawhney - Director
- Neeru Sawhney - Director
Paviour Pharmaceuticals reported a net profit of ₹1.46 Cr (net margin 1.7%) and EBITDA of ₹2.52 Cr (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Paviour Pharmaceuticals is 15% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Paviour Pharmaceuticals is 07AABCP9154E1ZF, registered in Delhi. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 19AABCP9154E1ZA (West Bengal), 22AABCP9154E1ZN (Chhattisgarh), 27AABCP9154E1ZD (Maharashtra).
The CIN (Corporate Identification Number) of Paviour Pharmaceuticals is U24231DL1998PTC095875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Paviour Pharmaceuticals has 3 court cases on record: 3 filed against it. Most are in the high courts.
Paviour Pharmaceuticals was incorporated on 01 September 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Paviour Pharmaceuticals has 17 deals on record (11 secondary share transfers, 6 funding rounds), with disclosed funding of ₹3 Cr; the latest was in March 2024.
The peers of Paviour Pharmaceuticals by revenue are Omkar Medical Distributors Private Limited, SRS Pharmaceuticals Private Limited, Amtec Health Care Private Limited, Shiva Medi Services Private Limited, Innovcare Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).